Natale Marzari e-mail fonama@fonama.org Tel. 0039 335 250742

Neuromuscular  Traduzione di Natale Marzari

Home, grave, Indice alfabetico, Collegamenti, Patologia, Molecole, Sindromi, Muscoli,

Giunzioni neuromuscolari, Nervi, Spinale, Atassia, Anticorpi e Biopsia, Informazioni per i pazienti

Tuesday 13 December 2011


Alan Pestronk: Bibliografia

INVITED PROFESSORSHIPS, LECTURES AND SEMINARS

1. Invited Seminar, University of New Messico. Title: Miastenia grave. Albuquerque, New Messico, August 1976.

2. Invited Presentation, periferica Nervi Society, Biennial Conference. Title: Motorio Nervi Sprouting. Airlie, Virginia, August 1977.

3. Invited Discussant, U.S. Department of Labor. Title: Epidemic of Neuropatia in Polyurethane Foam Plants. Washington, D.C., April 1978.

4. Invited Seminar, University of Michigan. Title: Motorio Neuron Sprouting e ACETILCOLINA Receptors. Ann Arbor, Michigan, April 1978.

5. Invited Lecture, University of Oregon Neuroscience Council. Title: Epidemic of Tossici Neuropatia. Portland, Oregon, December 1979.

6. Invited Lecture, Muscular Dystrophy Associazione Quadrennial Meeting - "Diseases of the Motorio Unit." Title: Motorio Nervi Outgrowth. Key Biscayne, Florida, giugno 1980.

7. Invited Presentation, New York Academy of Science Quadrennial Meeting on "Miastenia grave." Title: Experimental Trattamenti of Miastenia grave. New York, New York, December 1980.

8. Invited Presentation, Gordon Conference on Aging. Title: Aging e the Giunzioni neuromuscolari. Ventura, California, February 1982.

9. Invited Lecture, Vth International Congress on Neuromuscular Malattia. Title: Sprouting e rigenerazione of Motorio Nerves. Marseille, France, September 1982.

10. Invited Presentation, Workshop on "Immune Responses to Cell Membrane Receptors e their Ligands as Causes of Neurologic Diseases." Title: Neurotransmitters as Trophic Factors. Rancho Mirage, California, February 1983.

11. Medical Leader - Neurology in Cina. Invited Lectures in Peking -Miastenia grave, Tianjin - Botulismo, Shanghai - Polimiosite, Demenza, April 1983.

12. Chairman - Sessions on Miastenia grave, American Academy of Neurology, Dallas, April 1985.

13. Invited Presentation, New York Academy of Sciences Meeting on Miastenia grave. Title: "Polimiosite." New York, New York, March 1986.

14. Visiting Professor, Department of Neurology, The University of New Messico. Title: Plasticity of the Giunzioni neuromuscolari," giugno 1986.

15. Visiting Professor, Department of Neurology, Washington University-St. Louis. Title: "inferiori Motorio Neuron Sindromi" February. 1989.

16. Invited Presentation, American Academy of Neurology Clinica Neurochemistry Decorso. Title: "Botulinum Toxin," April 1989.

17. Invited Presentation, American Academy of Neurology Peripheral Neuropatia Decorso. Title: "Motorio Neuropatie," April 1989.

18. Visiting Professor, "Anti GMI Ganglioside Anticorpi," University of Maryland, Può 1989.

19. Invited Presentation: "Anti-glycolipid Anticorpi in inferiori Motorio Neuron Sindromi," Georgetown University School of Medicine, giugno 1989.

20. Annual Speaker: Muscular Dystrophy Associazione - Mississippi Valley Chapter, "Muscular Dystrophy", novembre 1989.

21. Invited Speaker: Conference on ALS Tucson AZ. Title: "Immunology of ALS," December 1989.

22. Invited Speaker: las Immunological Society, "Antiglycolipid Anticorpi," Può 1990.

23. Visiting Professor: Iowa-Midwest Neurological Society, "Immune Neuropatie" "Motorio Neuropatie," giugno 1990.

24. Visiting Professor: St. Louis University, "Immune Neuropatie," giugno 1990.

25. Invited Speaker: VII International Congress of Neuromuscular Malattia, Munich, West Germany, "Immune Neuropatie," September 1990.

26. Invited Speaker: St. John's Mercy Medical Center, St. Louis, MO, "Immune Neuropatie e Antiglycolipid Anticorpi," gennaio 1991.

27. Invited Speaker: Gangliosides: The Pharmacology of Neuronal Plasticity, Rome, Italy, "Anti-ganglioside Anticorpi," February 1991.

28. Invited Speaker: American Academy of Neurology, "Infanzia CIDP," April 1991.

29. Decorso Director: American Academy of Neurology, "Seminar on ALS," April 1991.

30. Visiting Professor: Columbia Neurological Group, Columbia, MO "Diagnosis e Trattamento of Immune Neuropatie," July 1991.

31. Visiting Professor: Massachusetts Generale Hospital - Harvard Medical School, Boston Mass, "Autoimmune Motorio Neuropatie," October 1991.

32. Visiting Professor: University of Kentucky, Lexington, KY, "Motorio Neuropatie," December 1991.

33. Visiting Professor: Vanderbilt School of Medicine, Nashville, TN., "Motorio Neuropatie," February 1992.

34. Visiting Professor: Yale University, New Haven, CT., "Autoimmune Neuropatie," February 1992.

35. Invited Speaker: ALS Associazione,- Greater St. Louis Chapter - Support Group, "ALS - New Advances," St. Louis, MO, February 1992.

36. Visiting Professor: Indiana University, Indianapolis, IN, "Multifocal Neuropatia motoria," "Autoimmune Neuropatie," March 1992.

37. Invited Speaker: American Academy of Neurology Decorso - Immunosopressione, San Diego, CA "Polyneuropatie," Può 1992.

38. Visiting Professor: University of Alberta, Edmonton Alberta, Canada, "Autoimmune Neuropatie," giugno 1992.

39. Visiting Professor: University of Michigan, Ann Arbor, MI, "Motorio Neuropatie" "Polyneuropatie e Autoanticorpi," giugno 1992.

40. Invited Speaker: Multifocal Neuropatia motoria: Diagnostic Criteria e Therapeutical Strategies. Milan, Italy, "Antiglycolipid Anticorpi in Multifocal Neuropatia motoria e Motorio Neuron Malattia," July 1992.

41. Invited Speaker: Associazione of Medical Laboratorio Immunologists - Plenary Session, Alexandria, VA, "Neuropatia Associata Con Monoclonal Gammopathies," August 1992.

42. Invited Speaker: Research Updates, Controversial Issues in ALS. Venice, Italy, "Autoanticorpi in Motorio Neuron Malattia e Neuropatia motoria," September 1992.

43. Invited Speaker: Molecular Basis of Clinica Neurology, Madison WI, "Anti-GM1 Ganglioside Anticorpi," October 1992.

44. Invited Speaker: Yiniziale Meeting - The Amyotrophic Lateral Sclerosis Associazione - Greater St. Louis Chapter, St. Louis MO, "ALS," December 1992.

45. Visiting Professor: Wayne State University, Detroit, MI, "Motorio Neuropatie e Autoanticorpi," gennaio 1993.

46. Visiting Professor: St. John's Mercy Medical Center, St. Louis, MO, "Autoanticorpi e Immune Polyneuropatie," March 1993.

47. Invited Speaker: Neuroimmunology for the Clinician, New Haven CT, "Immune Mediated Neuropatie," April 1993.

48. Invited Speaker: American Academy of Neurology Decorso - Immunosopressione, New York City, NY, "Autoimmune Polyneuropatie," Può 1993.

49. Invited Speaker: Meccanismi e Immunotherapies in Immune-mediata Neurological Diseases, Amelia Island, FL, "Multifocal Neuropatia motoria con Blocco di conduzione: Meccanismi e Therapy," giugno 1993.

50. Visiting Professor: University of New Messico, Albuquerque, NM, "Autoimmune Motorio Neuropatie," "GALOP Sindromi e Immune Sensorio Polyneuropatie," October 1993.

51. Visiting Professor: Johns Hopkins School of Medicine, Baltimore, MD, "GALOP Sindromi e Autoimmune Polyneuropatie," October 1993.

52. Visiting Professor: New Jersey College of Medicine e Dentistry, Newark NJ, "Autoimmune Polyneuropatie," March 1994.

53. Invited Speaker e Simposio Chairman: VIII International Congress of Neuromuscular Malattia, Kyoto, Giappone, "Multifocal Neuropatia motoria e Conduction Block," July, 1994.

54. Invited Speaker: "Immune neuropatie" Orlando, FL September 1994.

55. Invited Lecture: "Treatable Motorio Neuropatie", St. Louis Neurological Society, St. Louis, MO, September 1994.

56. Invited Lecturer: Miastenia grave Decorso, "Surgery of the thymus gland", American College of Surgeons, Chicago, IL, October 1994.

57. Invited Lecturer: "ALS con paraproteins e autoanticorpi" Decorso: Current issues in the pathogenesis e Terapia of ALS, Marseille, France, October 1994.

58. Visiting Professor: "Immune neuropatie sensorie" National Institutes of Health, Washington, D.C., February 1995.

59. Invited Lecturer: "Patologia muscolare", Decorso: Adulti e pediatric neurology in primary care medicine. Methodist Hospital of Indiana, IN, Può 1995.

60. Invited lecture: "Immune neuropatie", Decorso: Immunosuppressive trattamento, American Academy of Neurology, Seattle, WA, Può 1995.

61. Participant: Workshop on Clinica research in ALS, Rochester, MN, giugno 1995.

62. Invited Lecturer: "Peripheral neuropatie", Decorso: Contemporary clinical neurology symposium, Vanderbilt University School of Medicine, Hilton Head Island, SC, July 1995.

63. Invited Lecturer: "Sensorio polineuropatia", University of Vermont School of Medicine, August 1995.

64. Visiting Professor: "Immune Neuropatie", Instituto De Ciencias Neurologicas, Lima, peru, August 1995.

65. Visiting Professor: "Immune Neuropatie", State University of New York a Stony Brook, Stony Brook, NY, September 1995.

66. Invited Lecturer: Decorso: 1995 Diabete Update "Diabetic Neuropatie" Cape Girardeau, MO, September 1995.

67. Visiting Professor: "Post paralysis paralysis", " Polyneuropatie e autoanticorpi", Vanderbilt University School of Medicine, Nashville, TN, October 1995.

68. Visiting Professor: "Miastenia grave", St. John's Medical Center, St. Louis, MO, gennaio 1996.

69. Invited Lecturer: "Multifocal motor neuropatie", Decorso: Neuroimmunology e Terapia of immune-mediata neurologiche e neuromuscular malattia, San Francisco, CA , March 1996.

70. Invited Lecturer: "Immune neuropatie", Decorso: Immunosuppressive trattamento, American Academy of Neurology, San Francisco, CA, March 1996.

71. Invited Lecturer: "Anti-GM1 anticorpi", Decorso:, Antinerve Anticorpi American Academy of Neurology, San Francisco, CA, March 1996.

72. Visiting Professor: Lendowne-Rogowski Lecture "Autoimmune neuropatie", Yale University School of Medicine New Haven, CT, April 1996.

73. Visiting Professor: "Internist's approach to neuromuscular diseases", VA Hospital, St. Louis, MO, giugno 1996.

74. Invited Lecturer: National Institutes of Allergy e Infectious Diseases workshop; Development of Guillain-Barre Sindrome Following Campylobacter Infezione, "Anti-GM1 anticorpi in GBS", Bethesda, MD, August 1996.

75. Visiting Professor: "anticorpi mediata Neuropatie"; "Debolezza in the ICU", Emory University School of Medicine, Atlanta, GA, October, 1996.

76. Invited Speaker: "Immune neuropatie e autoanticorpi", St. Vincent's Hospital, New York, NY, December 1996.

77. Invited Speaker: "Immune neuropatie e autoanticorpi", Garden City, New York, Dinner Speaking Program, December, 1996.

78. Invited Speaker: "Advances in ALS" Greater St. Louis ALS Associazione, St. Louis, MO, February 1997

79. Visiting Professor: "anticorpi-mediata neuropatie", University of Missouri Columbia, MO, March 1997.

80. Visiting Professor: "Immune neuropatie e autoanticorpi", Massachusetts Generale Hospital, Boston, MA, March 1997.

81. Seminar Speaker: "Diagnosing immune neuropatie", Baltimore, MD, April 1997.

82. Invited Speaker: "Immune neuropatie e autoanticorpi" Neuroimmunology Decorso, Boston, MA, April 1997.

83. Invited speaker: "Advances in neuromuscular research", 1997 MDA Awsononess Seminar, St. Louis, MO, Può 1997

84. Visiting Professor: "Immune demielinizzante polineuropatia", Allegheny Hospital, Thomas Jefferson School of Medicine, philadelphia, pA, giugno 1997

85. Platform Presenter: "Measurement of anti-GM1 anticorpi", periferica Nervi Society, Cambridge, England, July 1997

86. Invited Speaker: "Demielinizzanti neuropatie e autoanticorpi", South Carolina Neurologic Society, Hilton Head Island, SC, August 1997.

87. Visiting Professor: "Demielinizzanti polineuropatia e autoanticorpi", Northwestern School of Medicine, Chicago, IL, October 1997

88. Visiting Professor: "Immune demielinizzante polineuropatia", University of Washington School of Medicine, Seattle Washington, December 1997

89. Speaker: "Immune Neuropatie", Grand Rounds, Washington University School of Medicine, gennaio 1998.

90. Visiting Faculty: "Immune Neuropatie", "DNA ripetuto sequences e neurologiche Malattie", Southern Clinica Neurological Society, Bay of Huatulco, Messico, gennaio 1998.

91. Invited participant: "Neuropatia Centers Meeting", Dorado Beach, puerto Rico, gennaio 1998.

92. Speaker: "DNA ripetuto sequences e neurologiche Malattie", Grand Rounds, Washington University School of Medicine, February 1998.

93. Visiting Professor: "Demielinizzanti polineuropatia e autoanticorpi", Mt. Sinai School of Medicine, New York City, NY, February 1998.

94. Chairman: NIH Special Study Section, March 1998.

95. Invited Participant: "Expert panel consensus on the use of IVIG for Neurologic diseases. Washington, DC, April 1998.

96. Visiting Professor: "Demielinizzanti polineuropatia e autoanticorpi", SUNY Syracuse, NY, April 1998.

97. Invited speaker: "Miastenia grave", Neuroimmunology Decorso, American Academy of Neurology, Minneapolis, Minnesota, April 1998. 98. Invited instructor: "Computers in Neurology", Beginner e Advanced Computer Decorso, American Academy of Neurology, Minneapolis, Minnesota, April 1998.

99. Visiting Professor: "Immune-mediata demielinizzante polineuropatia", Cleveland Clinic, Cleveland, Ohio, Può 1998.

100. Swank Visiting Professor: "Autoanticorpi e polineuropatia", " Infiammatorie miopatie" University of Oregon, portland, Oregon, giugno 1998.

101. Visiting Professor: "Immune demielinizzante polineuropatia", University of Florida, Gainesville, Florida, July 1998.

102. Invited speaker: "Debolezza in the intensive care unit", Department of Anesthesia, Washington University, St. Louis, July 1998.

103. Invited participant: "Gene Terapia for muscolare dystrophy", Muscular Dystrophy Associazione, Tucson, Arizona, August 1998.

104. Invited speaker: "Anti-sulfatide anticorpi e periferica neuropatia", periferica Nervi Society, Epidaurus, Greece, August 1998.

105. Workshop leader: "Antiglycolipid anticorpi e polineuropatia", "Paraneoplastico neuropatie", International Congress of Neuromuscular Malattia, Adelaide, Australia, September 1998.

106. Invited speaker: "inferiori Motorio Neuron Sindromi", International Congress of Neuromuscular Malattia, Adelaide, Australia, September 1998.

107. Visiting Professor: "Immune demielinizzante polineuropatia", University of Oklahoma, Oklahoma City, Oklahoma, October 1998.

108. Invited speaker: "Paraneoplastico neuropatie" Presidential symposium, American Academy of Neurology, Montreal, Quebec, Canada, October 1998.

109. Visiting Professor: "Immune demielinizzante polineuropatia", University of Texas, Southwestern, Dallas, Texas, novembre 1998.

110. Visiting Professor: "Immune demielinizzante polineuropatia", Yale University School of Medicine, New Haven, Connecticut, December 1998.

111. Visiting Professor: "Immune demielinizzante polineuropatia", University of California, San Diego, San Diego California, gennaio 1999.

112. Invited speaker: "Cronico immune demielinizzante neuropatie" Decorso: Neuroimmunology e Terapia of immune-mediata neurologiche e neuromuscular malattia, Toronto, Ontario, Canada, April 1999.

113. Decorso Director "Muscoli Biopsy", Dinner seminar, American Academy of Neurology, Toronto, Ontario, Canada, April 1999.

114. Invited speaker: "Autoanticorpi e demielinizzante neuropatie" Quest Diagnostics, San Juan de Capistrano, CA, April 1999.

115. Visiting professor: "Cronico immune demielinizzante ", "Paraneoplastico neuromuscular sindromi", University of Miami, Miami, FL. giugno 1999.

116. Visiting professor: "Cronico immune demielinizzante neuropatie", University of North Carolina, Chapel Hill, NC, September 1999.

117. Invited speaker: "Cronico immune demielinizzante neuropatie", Duke University; Durham, NC, September 1999.

118. Invited speaker: "Cronico immune demielinizzante neuropatie", University of Melbourne, Melbourne, Victoria, Australia, October 1999.

119. Visiting professor: "Cronico immune demielinizzante neuropatie", SUNY Buffalo, Buffalo, NY, novembre 1999.

120. Visiting professor: "Cronico immune demielinizzante neuropatie", University of Texas, Houston, TX, December 1999.

121. Invited speaker: "Cronico immune demielinizzante neuropatie" "Infiammatorie miopatie", Neurological Update 2000, University of Miami, Miami, FL, gennaio 2000.

122. Visiting Professor: "Cronico immune demielinizzante neuropatie", Harvard-Longwood Boston, MA, March 2000.

123. Visiting Professor: "Cronico immune demielinizzante neuropatie", University of California, Davis, Sacramento, CA, March 2000.

124. Invited speaker: "Cronico immune demielinizzante neuropatie" Kaiser-Permanente Neurology Simposio, Santa Monica, CA, March 2000.

125. Program chairman e speaker: "Miastenia grave 2000" Miastenia grave: Clinica e Concetti di base, Miastenia grave Foundation of America, St. Louis, MO, April 2000.

126. Invited speaker: "Neuromuscular Malattie: Principali of Terapia" Decorso: Immunosuppressive trattamento for neurologists, San Diego, CA, April 2000.

127. Decorso Director "Muscoli Biopsy", Dinner seminar, American Academy of Neurology, San Diego, CA, Può 2000.

128. Visiting Professor: "Cronico immune demielinizzante neuropatie", University of Colorado, Denver, CO, giugno 2000.

129. Invited speaker: "Anticorpi e Polyneuropatie" Kroc Neuroscience Simposio 2000; Johns Hopkins School of Medicine, Baltimore, MD, giugno 2000.

130. Visiting Professor: "Cronico immune demielinizzante neuropatie", University of California, San Francisco, CA, September 2000.

131. Invited speaker: "Immune-mediata Demielinizzanti Polyneuropatie" "Multifocal Neuropatia motoria" First Portoghese Congress on Neuromuscular Diseases, Estoril, portugal, October 2000.

132. Visiting Professor: "Cronico immune demielinizzante neuropatie", Southern Illinois University, primaverafield, IL, novembre 2000.

133. Invited speaker: "Cronico immune demielinizzante neuropatie", North Carolina Neurological Society Annual Meeting, Greensboro, NC, novembre 2000.

134. Invited participant: "Infanzia CIDP", 88th ENMC Conference, Naarden, Netherlands, December 2000.

135. Invited speaker: "Cronico immune demielinizzante neuropatie", phoenix AZ, February 2001.

136. Invited speaker: "New concepts in miopatie immunitarie", St. Johns Hospital Medical Grand Rounds, St. Louis, MO, February 2001.

137. Invited speaker: "Neuromuscular malattia e the internet: Learning e teaching", Israeli Neuromuscular Society, Tel-Aviv, Israel, March 2001.

138. Invited speaker: "Cronico immune demielinizzante neuropatie" "New concepts in miopatie immunitarie", Israeli Society of Clinica Neurophysiology, Tel-Aviv, Israel, March 2001.

139. Invited speaker: "Trattamento of immune mediata neuromuscular Malattie", Simposio: "Glaucoma: Learning from altre neurodegeneraziones" Sarasota, FL March 2001.

140. Visiting Professor: "Cronico immune demielinizzante neuropatie: Diagnosis e Trattamento", Johns Hopkins School of Medicine, Baltimore, MD, April 2001.

141. Invited speaker: "Neuromuscular Malattie: Principali of Terapia" Decorso: Immunosuppressive trattamento for neurologists, philadelphia, pA, Può 2001.

142. Decorso Director "Nervi e Muscoli Biopsy", Dinner seminar, American Academy of Neurology, philadelphia, pA, Può 2001.

143. Invited speaker: "Neuromuscular malattia e the internet: Learning e teaching" Decorso: Computers e Neurology, philadelphia, pA, Può 2001.

144. Visiting Professor: "Cronico immune demielinizzante neuropatie: Diagnosis e Trattamento", Northwestern School of Medicine, Chicago, IL, Può 2001.

145. Invited speaker: "Doloranti Neuropatie", Dolore gestione group, Washington University School of Medicine, St. Louis, MO, giugno 2001.

146. Visiting Professor: "Valurazione of Neuromuscular Disorders" "Muscular Dystrophies" "Cronico immune demielinizzante neuropatie" "Miopatie immunitarie" Contemporary Neurology Decorso, Vanderbilt School of Medicine, Hilton Head, SC, July 2001.

147. Invited speaker: "Cronico Immune Motorio Neuropatie", World Muscoli Society, Snowbird, UT, September 2001.

148. Invited speaker: "Cronico Immune Motorio Neuropatie", Grand Rounds, Neurology, Washington University School of Medicine, September 2001.

149. Invited speaker: "Cronico immune demielinizzante neuropatie", Orange County Neurological Society, Costa Mesa, CA, October, 2001.

150. Visiting Professor: "Cronico immune motor neuropatie", University of California, Irvine, Orange, CA, October, 2001.

151. Invited speaker: "Cronico immune demielinizzante neuropatie", Allegheny Hospital Pittsburgh, pA, October, 2001.

152. Invited speaker: "Rituxan trattamento of IgM Associata Neuropatie", Maui, HI, gennaio 2002.

153. Carrell-Krusen Lecturer: "New Concepts in Miopatie infiammatorie" University of Texas Southwestern, Dallas, TX, February, 2002.

154. Visiting Professor: "Immune Demielinizzanti Neuropatie: Diagnosis e Trattamento" University of Texas Southwestern, Dallas, TX, February, 2002.

155. Invited speaker: "New Concepts in Miopatie infiammatorie" University of Melbourne, Melbourne, Victoria, Australia, March, 2002.

156. Visiting Professor: "Immune Demielinizzanti Neuropatie: Diagnosis e Trattamento" New Jersey College of Medicine e Dentistry, Newark, NJ, March, 2002.

157. Invited speaker: "IgM associata Peripheral Neuropatia" International Waldenström's Macroglobulinemia Foundation, Las Vegas, NV, April, 2002.

158. Decorso Director "Practical Immunotherapy of Neuromuscular Disorders", American Academy of Neurology, Denver, CO, April 2002.

159. Invited speaker: "Neuromuscular Disorders" Decorso: Crossfire, Denver, CO, April 2002.

160. Visiting Professor: "Immune Demielinizzanti Neuropatie: Diagnosis e Trattamento" University of Maryland College of Medicine, Baltimore, MD, Può, 2002.

161. Invited speaker: "Neuromuscular Malattia e the Internet", International Congress of Neuromuscular Diseases, Vancouver, BC, Canada, July 2002.

162. Visiting Professor: "Immune Demielinizzanti Neuropatie: Diagnosis e Trattamento" Baylor College of Medicine, Houston, TX, August, 2002.

163. Invited speaker: "Antigenic targets of IgM Proteina M in Waldenström's macroglobulinemia", 2a International Workshop on Waldenström's macroglobulinemia, Athens, Greece, September 2002.

164. Invited speaker: "Demielinizzanti neuropatie con conduction block" University of Melbourne, Melbourne, Victoria, Australia, October, 2002.

165. Visiting Professor, Davee Guest Lecturer: "New Concepts in Miopatie infiammatorie", Northwestern School of Medicine, Chicago, IL, novembre 2002.

166. Invited speaker: "New Concepts in the diagnosi e trattamento of Miopatie infiammatorie", Department of Neurology Grand Rounds, Washington University School of Medicine, Saint Louis, MO, gennaio 2003.

167. Invited speaker: "New Concepts in the diagnosi e trattamento of Miopatie infiammatorie", San Diego Neurological Society, San Diego, CA, February 2003.

168. Visiting Professor, "Immune Demielinizzanti Neuropatie: Diagnosis e Trattamento" University of California, San Diego, CA, February 2003.

169. Visiting Professor, "Immune Demielinizzanti Neuropatie: Diagnosis e Trattamento" University of Massachusetts, Worcester, MA, March 2003.

170. Invited speaker: "New Concepts in the diagnosi e trattamento of Miopatie infiammatorie", Division of Rheumatology Grand Rounds, Washington University School of Medicine, Saint Louis, MO, April 2003.

171. Decorso Director "Practical Immunotherapy of Neuromuscular Disorders", American Academy of Neurology, Honolulu, HI, April 2003.

172. Visiting Professor, "Immune Demielinizzanti Neuropatie: Diagnosis e Trattamento" Medical College of Wisconsin, Milwaukee, WI, Può 2003.

173. Visiting Professor, "Immune Demielinizzanti Neuropatie: Diagnosis e Trattamento" Hahnemann School of Medicine, philadelphia, pA, giugno 2003.

174. Visiting Professor, "Immune Demielinizzanti Neuropatie: Diagnosis e Trattamento" University of Wisconsin, Madison, WI, August 2003.

175. Visiting Professor, "Immune Demielinizzanti Neuropatie: Diagnosis e Trattamento" University of Kansas, Kansas City, MO, September 2003.

176. Decorso Director "Practical Immunotherapy of Neuromuscular Disorders", American Academy of Neurology, San Francisco, CA, April 2004.

177. Visiting Professor, "Immune Demielinizzanti Neuropatie: Diagnosis e Trattamento" University of Illinois, Chicago, IL, October 2004.

178. Invited speaker: "Cronico immune demielinizzante neuropatie" "Infiammatorie miopatie, New Concepts", Neurological Update 2005, University of Miami, Miami, FL, gennaio 2005.


ABSTRACTS

1. Pestronk, A., Drachman, D.B. (1975) Trophic regulation of ACh recettores: Parziale effect of ACh transmission. Neurology 25:373.

2. Pestronk, A., Drachman, D.B., e Griffin, J.W. (1976) Trophic regulation of ACh recettores: Parziale effect of usage. Neurology 26:348.

3. Toyka, K.V., Griffin, D.E., pestronk, A., Fischbeck, K.H., Kao,I., e Drachman, D.B. (1976) Miastenia grave: passive transfer from man to mice con immunoglobulins. Fed Proc 23:437.

4. Pestronk, A., e Drachman, D.B. (1977) Disuso dei Muscoli evokes nerve sprouting. Neurology 27:393-394.

5. Pestronk, A., e Drachman, D.B. (1978) Motorio nerve terminale sprouting e ACETILCOLINA (ACh) recettores. Neurology 28:355.

6. Pestronk, A., e Drachman, D.B. (1978) The effect of aging on nerve sprouting. Ann Neurol 4:164.

7. Pestronk, A., e Drachman, D.B. (1978) Recettori dell'acetilcolina induce morphological cambiamenti in motor nerve terminals. Presented a IVth International Congress on Neuromuscular Malattia, Montreal, Quebec, Canada.

8. Pestronk, A., Keogh, J.P., e Griffin, J.W. (1979) Dimethylamino-propionitirile (DMAPN) intoxication: a new industrial neuropatia. Neurology 29:549.

9. Pestronk, A., Drachman, D.B., Stanley, E.F., e Adams, R.N. (1980) Trattamento of experimental autoimmune myasthenia gravis (EAMG) using single, alto-dose cyclophosphamide. Neurology 30:388.

10. Hemphill, M., pestronk, A., Walsh, T., parhad, I.M., Clark, A., Rosenshein, N. (1980) Neuropatia sensoria in cis platinum chemotherapy. Neurology 30:429.

11. Parhad, I.M., pestronk, A., price, D.L., e Drachman, D.B. (1980) Membrane miopatia: morphologic similarities to Duchenne's muscolare dystrophy. Neurology 30:422.

12. Pestronk, A., Drachman, D.B., Stanley, E.F. (1980) Therapeutic strategies in experimental autoimmune myasthenia gravis. Presentation a New York Academy of Sciences. New York, New York.

13. Stanley, E.F., pestronk, A., Drachman, D.B., Griffin, J.W., e Price, D.L. (1980) The role of ACh transmission in the neural regulation of Muscoli resting membrane potential. Soc for Neuroscience, Cincinnati, Ohio. Soc Neurosci Abst 6:384.

14. Pestronk, A., Drachman, D.B., Josifek, L.F. (1981) Measurement of junctional ACh recettores in myasthenia gravis: diagnostic value e clinical correlata. Neurology 31(2):83.

15. Pestronk, A., (1981) "Hidden" a-bungarotoxin legante sites in rat skeletal Muscoli in vivo. Soc Neurosci Abst 7:701.

16. Pestronk, A., e Drachman, D.B. (1982) Reduction of ACETILCOLINA recettores (AChRs) in polimiosite. Neurology 32:A120.

17. Pestronk, A., e Drachman, D.B. (1982) Therapeutic strategy eliminates anti-AChR anticorpo risposta in experimental myasthenia gravis. Vth International Congress on Neuromuscular Diseases.

18. Drachman, D.B., pestronk, A., Tutschka, p. (1982) Cyclosporin A in the trattamento of experimental autoimmune myasthenia gravis. Vth International Congress on Neuromuscular Diseases.

19. Pestronk, A., e Drachman, D.B. (1984) Motorio nerve sprouting. Effects of a-bungarotoxin e anti-AChR anticorpo. Soc for Neurosci 10:1020 (Part II).

20. Pestronk, A., e Drachman, D.B. (1984) Motorio nerve sprouting: effects of a-bungarotoxin e anti-AChR anticorpo. Ann Neurol 16:147. 21. Pestronk, A., Tech, R., e Drachman, D.B. (1985) Effects of dimethyl sulfoxide on the humoral immune risposta to ACETILCOLINA recettores. Neurology 35:101.

22. Cornblath, D., pestronk, A., Yee, W.C., e Kuncl, R.W. (1985) Congenite myasthenia con aumentati numero of ACETILCOLINA recettores a neuromuscular junction. Muscoli e Nervi 8:611.

23. Yee, W.C., e Pestronk, A. (1985) Motorio nerve terminale outgrowth induces rapida modification of junctional ACETILCOLINA recettore clusters in adulti mammalian skeletal Muscoli. Soc for Neurosci 11:1146.

24. Griffin, J.W., Hoffman, R.N., Gold, B.G., pestronk, A., price, D.L., e Cork, L.C. (1986) Somatofugal axonal atrofia: a sensitive iniziale marcatore of axonal disfunzione. ANA Meeting. Ann Neurol. 20:131A.

25. Yee, W.C., e Pestronk, A. (1986) Meccanismi of postsynaptic plasticity: modification of junctional ACETILCOLINA recettore clusters induced by motor nerve terminale outgrowth. VI International Congress on Neuromuscular Malattia.

26. Griffin, J.W., Gold, B.G., pestronk, A., Stanley, E.F., price, D.L., e Fahnestock, K. (1986) Experimental axonal atrofia produced by botulinum toxin. Neurology 36:80.

27. Kuncl, R.W., pestronk, A., Cornblath, D.R., e Yee, W.C. (1986) Morphometric analysis of a congenita myasthenic sindrome characterized by aumentati ACETILCOLINA recettores. Neurology 36:162.

28. Feldman, E.L., Hoffman, p.N., pestronk, A., e Griffin, J.W. (1986) Cytoskeletal organization durante axonal outgrowth. Soc for Neurosci 12:277.

29. Pestronk, A., e Drachman, D.B. (1986) Meccanismo of action of lithium on ACETILCOLINA recettore metabolism in skeletal Muscoli. Soc for Neurosci 12:308. 30. Gold, B.G., Griffin, J.W., pestronk, A., Hoffman, p.N., Stanley, E.F., e Price, D.L. (1986) Somatofugal axonal atrofia produced by botulinum toxin. Soc for Neurosci 12:1108.

31. Yee, W.C., e Pestronk, A. (1986) Meccanismi of postsynaptic plasticity: modification of junctional ACETILCOLINA recettore clusters induced by motor nerve terminale outgrowth. Soc for Neurosci 12:1106.

32. Alderson, K., pestronk, A., Griffin, J.W., e Drachman, D.B. (1987) Motorio nerve terminale sprouts express local signals for Schwann cellule mitogenesis e myelination. Neurology 37:355.

33. Pestronk, A. (1987) The first neurology book: "De cerebri morbis..." (1549) by Jason Pratensis. Neurology 37:240.

34. Pestronk, A., e Drachman, D.B. (1987) Motorio nerve outgrowth: ridotta capacità for sprouting in the terminals of longer assoni. Neurology 37:254.

35. Drachman, D.B., DeSilva, S., Ramsey, D., e Pestronk, A. (1987) "Sero-negative" myasthenia gravis: a humorally-mediata variante of myasthenia. Neurology 37:214.

36. Corey, A.L., pestronk, A., Richman, D.P., e Drachman, D.B. (1987) Quantitation of ACETILCOLINA recettores per neuromuscular junction in rats con passively induced experimental myasthenia. Neurology 37:303.

37. Pestronk, A., Cornblath, D.R., Ilyas, A.A., Baba, H., Quarles, R.H., Griffin, J.W. (1987) A treatable cronica, multifocal, motor polineuropatia associata con anticorpi to a defined neural antigene. Ann Neurol 22:119A

38. Yee, W.C., pestronk, A. (1987) Cytoskeletal elements in motor nerve outgrowth in vivo: cambiamenti durante axonal rigenerazione e terminale sprouting. Soc for Neurosci 13(2):1479.

39. Yee, W.C., pestronk, A., Alderson, K. (1988) Regional eterogeneicità in the distal motor axon: three zones con distinctive components. Neurology 38(1):189.

40. Pestronk, A., Adams, R.N., Clawson, L., Cornblath, D.R., Drachman, D.B., Griffin, D., Kuncl, R.W. (1988) Multifocal motor neuropatia: caratteristiche cliniche dei pazienti con anti-GM1 ganglioside anticorpi. Neurology 38(1):251.

41. Alderson, K., pestronk, A., Griffin, J.W., Drachman, D.B. (1988) Motorio nerve terminale morfologia: a new diagnostic technique in periferica neuropatia. Neurology 38(1):351.

42. Pestronk, A. (1988) The first neurology book written in English: De morbis capitis... (1650), by Robert Pemell. Neurology 39(1):385.

43. Pestronk, A., Adams, R.N., Clawson, L., Cornblath, D., Kuncl, R.W., Griffin, D., Drachman, D.B. (1988) serico anticorpi to GM1 ganglioside in amyotrophic lateral sclerosis. Ann Neurology 24:122.

44. Yee, W.C., pestronk, A., Hahn, A.F. (1988) Laminin promotes motor nerve sprouting in vivo. Soc for Neurosci 14:1170.

45. Baba, H., Ilyas, A., pestronk, A., Cornblath, D., Griffin, J., Quarles, R. (1988) Anticorpi GM1 ganglioside in multifocal motor neuropatia. Am Soc Neurochem 19, 193.

46. Pestronk, A., Chaudhry, V., Feldman, E., Griffin, J.W., Cornblath, D.R., Denys, E.H., Glasberg, M., Kuncl, R.W., Olney, R.K., Yee, W.C. (1989) inferiori motor neuron sindromi defined by patterns of debolezza, nerve conduction anormalità, e alto titers of antiglycolipid anticorpi. Ann Neurol 26:121-122.

47. Rothstein, J.D., Kuncl, R.W., Clawson, L.L., Cornblath, D.R., Drachman, D.B., pestronk, A. (1989) Cerebrospinal fluid excitatory aminoacidi in amyotrophic lateral sclerosis. Ann Neurol 26:144.

48. Alderson, K., Griffin, J.W., pestronk, A. (1989) Assonale swellings in neuromuscular malattia: A comuni reflection of neurofilament trasporto alteration? Ann Neurol 16:146.

49. Drachman, D.B., Alving, C., McIntosh, K.R., pestronk, A., Adams, R.N. (1989) Gangliosides elicit Cellule T-independent anticorpo risposta. Ann Neurol 26:150.

50. Alderson, K., pestronk, A., Drachman, D.B. (1989) Anormalee myelination of distal motor nerves in amyotrophic lateral sclerosis e periferica neuropatie. Ann Neurol 26:166-167.

51. Feldman, E.L., pestronk, A., Bromberg, M.B., Albers, J.W. (1989) Multifocal demielinizzante polineuropatia: An electrodiagnostic e therapeutic profile. Neurology 39:319.

52. Pestronk, A., Adams, R.N., Kuncl, R.W., Drachman, D.B., Clawson, L.L., Cornblath, D. (1989) differenziale effects of Prednisone e Ciclofosfamide on autoanticorpi in umana neuromuscular Malattie. Neurology 39:219.

53. Cornblath, D.R., Kuncl, R.W., Mellitus, E.D., Quaskey, S.A., Clawson, L., Drachman, D.B. e Pestronk, A. (1990) Conduzione nervosa studies in amyotrophic lateral sclerosis (ALS). Neurology 40:4585.

54. Chaudhry, V., pestronk, A., Drachman, D. (1990) Different patterns of glycolipid anticorpo reactivity: più bassa motor neuron sindromi contro immunization. Neurology 40:1185.

55. Sesodia, S., Nemeth, p.M., Choksi, R.M., pestronk, A. (1990) alta energy metabolism in severely atrofica Fibre muscolari in dermatomiosite. Society for Neuroscience.

56. Pestronk, A., Li, F., Griffin, J., Feldman, E., Cornblath, D., Trotter, J., Windsor, B. (1990) Anticorpi to myelin-associata glicoproteina e sulfate in predominantly sensorio polineuropatia. American Neurological Associazione 28:239.

57. Moxley, R.T., Lorenson, M., Griggs, R.C., Mendell, J.R., Fenichel, G.M., Brooke, M. H., Miller, J. P. e CIDD Group. (1990) Diminuita breakdown of Muscoli proteina dopo prednisone Terapia in Duchenne dystrophy (DD): Journal of Neurol Science 98:295.

58. Griggs, R.C. Moxley, R.T., pandya, S., Mendell, J.R., King, W.M., Signore, L., Fenichel, G.M., Robison, J.R., Brooke, M.H., Matheson, N., pestronk, A., Florence, J., Schierbecker, J., Miller, J.P., Wilson, B., Baty, J. (1991) Randomized, controllata trial of prednisone e azathioprine in Duchenne dystrophy. Neurology (Abstract) 41 (Suppl 1) 183S.

59. Fenichel, G.M., Florence, J., pestronk, A., Miller, J.P., Baty, J., Wilson, B., Schierbecker, J. (1991) Prednisone slows strength decline in Duchenne Muscular Dystrophy: Due-anno observation. Neurology 41 (Suppl 1) 182S.

60. Kuncl, R.W., Drachman, D.B., Wittstein, I., Adams, R., Wiggins, W., Avila, O., pestronk, A., McIntosh, K., Maurath, d., DeSilva, S. (1991) Novel Terapia of experimental myasthenia gravis by reducing endocytosis of ACETILCOLINA recettores. Neurology 41 (Suppl 1) 140S.

61. Glasberg, M.R., pestronk, A. (1991) Ciclofosfamide trattamento in ALS pazienti con elevata anti-GM, ganglioside anticorpo titers. Neurology 41 (Suppl 1) 956S.

62. Sawchak, J.A., Sher, J.H., Kula, R.W., Shafiq, S.A., Norman, M., pestronk, A. (1991) Espressione of prenatal myosin heavy catena in myofibre of a subgroup dei pazienti con centronuclear miopatia. Neurology 41(Suppl 1) 1069P.

63. Simmons, Z., Feldman, E.L., pestronk, A. (1992) Heterogeneity in polineuropatia associata con elevata anti-MAG titers con e senza IgM monoclonal gammopathy. Neurology 42(3):333.

64. Connolly, A.M., pestronk, A. (1992) alta-titer serum anti-tubulin anticorpi sono a marcatore for cronica infiammatorie demielinizzante polineuropatia (CIDP). Neurology 42(3):409.

65. Olney, R.K., pestronk, A. (1992) Prednisone trattamento of multifocal predominantly motor neuropatia. Neurology 42(3):178.

66. Pestronk, A., Zhu, S., Feldman, D.L. (1992) A distinctive Modello of serum IgM reactivity to GM1 ganglioside e cyclophilin in multifocal motor neuropatia (MMN). Neurology 42(3):177.

67. ALS CNTF Trattamento Study(ACTS) Phase I-II Study Group: Cedarbaum, J.M., Charatan, M., Stambler Tarrytown, NY; Brooks, B.R., Sanjak, M., Madison WI; Mitsumoto, H., Szirony, K. Cleveland, OH; Neville, H., Ringel, S., Brinkmann, J., Denver, CO: Pestronk, A., Florence, J., St. Louis, MO; J. Wittes, Brittain, E., Washington, DC. (1993) The amyotrophic lateral sclerosis functional rating scale (ALSFRS): prospective validation e cambiamenti con il tempo. Neurology 43: A417.

68. ALS CNTF Trattamento Study(ACTS) Phase I-II Study Group: Cedarbaum, J.M., Charatan, M., Stambler Tarrytown, NY; Brooks, B.R., Sanjak, M., Madison WI; Mitsumoto, H., Szirony, K. Cleveland, OH; Neville, H., Ringel, S., Brinkmann, J., Denver, CO: Pestronk, A., Florence, J., St. Louis, MO; J. Wittes, Brittain, E., Washington, DC. (1993) Recombinant umana ciliary neurotrophic fattore (rHCNTF) in amyotrophic lateral sclerosis (ALS) pazienti: Phase I-II safety, tolerability e pharmacokinetic studies. Neurology 43:A416.

69. Lopate, G., pestronk, A., Zhu, S., Choksi, R., Li, F., Beiser, K. (1993) A Modello of serum IgM anti-GM1 anticorpo legante con specificity for motor neuropatia sindromi. Neurology 43:A343.

70. Al-Lozi, M., pestronk, A., Flaris, N., Yee, W.C., Cooper, J. (1993) SAMM sindrome: a subacute miopatia con myosin-deficienza fibre. Neurology 43:A279.

71. Pestronk, A., Choksi, R., Bieser, K., Goldstein, J.M., Adler, C.H., Caselli, R.J., George, E.B. (1993) Sindrome GALOP: A treatable autoimmune disturbi dell'andatura con più tardi-age insorgere. Ann Neurol 34:269.

72. Kornberg, A., pestronk, A., Bieser, K., Ho, T.W., McKhann, G.M., Griffin, J.W., Cornblath, D.R., Wu, H.S. (1993) The clinical correlata of alto titer IgG anti-GM1 anticorpi. Ann Neurol 34:268.

73. Parks B.J., pestronk A., Goldstein J.M. (1994) Elettrodiagnostica caratteristiche of neuropatia associata con anticorpi to sulfatide. Muscoli e Nervi 17:1119

74. Blume, G., pestronk, A., Goodnough, L.T. (1995) Anti-MAG-associata polineuropatia: miglioramento following immunotherapy con monthly plasma excambiamenti e intravenous cyclophosphamide. Neurology 45, 32P

75. Brooks, B.R., e the ALS CNTF trattamento study (ACTS) Phase II-III study group. Phase II-III double-blind, placebo-controllata clinical trial of subcutaneous administration of recombinant umana ciliary neurotrophic fattore (rHCNTF) in amyotrophic lateral sclerosis. Neurology 45, 1017P.

76. Blume, G., pestronk, A., Johns, D.R. (1996) Polimiosite con excessive numero of citocromo ossidasi-negative Fibre muscolari has characteristic caratteristiche cliniche e a poor risposta to Prednisone. Neurology 46, A116.

77. Parks, B.J., Lopate, G., Goldstein, J., Yee, W-C, pestronk, A. (1996) Antisulfatide anticorpi e polineuropatia sindromi: Electrophysiologic caratteristiche in pazienti con e senza serum IgM M proteine. Neurology 46(2), A234.

78. Al-Lozi, M.T., pestronk, A. (1996) Miopatie con serum IgM legante to the BJ antigene e IgM deposito in Muscoli endomysium. Neurology 46(2), A344

79. Lopate, G., parks, B.J., Goldstein, J. Pestronk, A., (1996) Antisulfatide anticorpi e polineuropatia sindromi: Caratteristiche cliniche in pazienti con e senza serum IgM Proteina M. Neurology 46(2), A380.

80. Pestronk, A., Choksi, R., Blume, G., Lopate, G. (1997) Multifocal motor neuropatia: serum IgM anti-GM1 ganglioside anticorpi detected using modified ELISA methods in 85% dei pazienti. Peripheral Nervi Society

LETTERS TO THE EDITOR:

1. Pestronk, A. (1990) A note about Genica Corporation. Also reply from the Editor-in-Chief Neurology 1323.

2. Pestronk, A. (1992) Gammopatia monoclonale e neuropatia. Ann Neurol 31:689.

3. Pestronk, A, Kornberg AJ. The clinical correlata of IgG antiganglioside anticorpi (a reply). Muscoli e Nervi 1995, December.

4. Pestronk, A. Esami for serum IgM legante to GM1 ganglioside in clinical practice Neurology 2000 54: 2353-2354.

BOOK REVIEWS:

1. Pestronk, A. (1997) Istologia of the nervous system of man e vertebrates. Neurology:48;299.

CHAPTERS AND INVITED REVIEWS

1. Drachman, D.B., Kao, I., pestronk, A., e Toyka, K.V. (1976) Miastenia grave as a recettore malattia. Ann NY Acad Sci 274:226-234.

2. Drachman, D.B., Kao, I., pestronk, A., Toyka, K.V., Griffin, J.W., e Winkelstein, J.A. (1976) Miastenia grave: a umana malattia of ACh recettores. In Patogenesi of Umano Muscular Dystrophies. Ed. L.P. Rowland. Excerpta Medica, Elsevier/North Holland, Inc. NY, pp. 111-120.

3. Griffin, J.W., price, D.L., Hoffman, p.N., Clark, A.W., Drachman, D.B., e Pestronk, A. (1979) Tossici axonal neuropatie. In Current Topics in Nervi e Muscoli Research. Eds. A. Aguayo e G. Karpati. Excerpta Medica, Amsterdam, pp. 282-291.

4. Drachman, D.B., pestronk, A., e Stanley, E.F. (1979) Patogenesi of myasthenia gravis as a malattia of ACETILCOLINA recettores. Neurotoxins 3:237-244.

5. Pestronk, A., Keogh, J., e Griffin, J.W. (1980) Dimethylaminopropionitrile. In Environmental e Clinica Neurotoxicology. Eds. P.S. Spencer e H.H. Shaumburg. Williams e Wilkens, Baltimore, Maryland, pp.424-429.

6. Pestronk, A., e Drachman, D.B. (1981) Therapeutic strategies in experimental autoimmune myasthenia gravis. Ann NY Acad Sci 337:278-291.

7. Drachman, D.B., Adams, R.N., Josifek, L.F., pestronk, A., e Stanley, E.F. (1981) anticorpi mediata mechanisms of ACh recettore perdita in myasthenia gravis: clinical relevance. Ann NY Acad Sci 337:175-188.

8. Drachman, D.B., pestronk, A., e Stanley, E.F. (1982) Neurotrophic interactions between nerves e Muscoli: role of ACETILCOLINA. In Diseases of the Motorio Unit. Ed. D.L. Schotland. John Wiley e Sons, Inc., NY. Chap. 8, pp.107-118.

9. Drachman, D.B., pestronk, A., Stanley, E.F., e Adams, R.N. (1982) Meccanismi of ACETILCOLINA recettore perdita in myasthenia gravis. In Diseases of the Motorio Unit. Ed. D.L. Schotland. John Wiley e Sons, Inc., NY. Chap. 16, pp. 215-232.

10. Pestronk, A., e Drachman, D.B (1982) Sprouting e rigenerazione of motor nerves. In Diseases of the Motorio Unit. Ed. D.L. Schotland. John Wiley e Sons, Inc., NY. Chap. 13, pp. 173-185.

11. Pestronk, A., e Drachman, D.B. (1984) Regulation of motor nerve outgrowth. In Neuromuscular Diseases. Eds. G. Serratrice, D. Cros, C. Desnuelle, J.L. Gastaut, J.F. Pellissier, J. Pouget, A. Schiano. Raven Press, NY, pp. 407-413.

12. Drachman, D.B., Stanley, E.F., pestronk, A., (1984) Neural regulation of Muscoli properties. In Neuromuscular Diseases. Eds. G. Serratrice, D. Cros, C. Desnuelle, J.L. Gastaut, J.F. Pellissier, J. Pouget, A. Schiano. Raven Press, NY, pp. 415-424. 13. Miller, N., pestronk, A. (1985) Therapy of myasthenia gravis. In Current Oculare Therapy 2. Eds. F.T. Fraunfelder, F.H. Roy, W.B. Saunders Co., pp. 193-194.

14. Pestronk, A. (1985) Polimiosite. In Current Therapy in Neurologic Malattia. Ed. R.T. Johnson. B.C. Decker, Inc., philadelphia, pp. 380-383. 15. Pestronk, A., e Drachman, D.B. (1987) anticorpi-mediata membrane anormalità in polimiosite: reduction of ACETILCOLINA recettores by immunoglobulin. Ann NY Acad Sci 505:357-367.

16. Drachman, D.B., De Silva, S., Ramsay, D., e Pestronk, A. (1987) Humoral pathogenesis of myasthenia gravis. Ann NY Acad Sci 505:90-105.

17. Pestronk, A., Li, F. (1991) Motorio neuron sindromi: associazione con antiglycolipid anticorpi. In Motorio Neuron Malattia ed. L.P. Rowland et al, Raven Press, New York, pp. 427-432.

18. Pestronk, A. (1991) Motorio neuropatie, motor neuron Malattie, e antiglycolipid anticorpi. Muscoli e Nervi 14:1429-10.

19. Kuncl, R.W., Wittstein, I., Adams, R.N., Wiggins, W.W., Avila, O., pestronk, A., McIntosh, K., Lucas, D., DeSilva, S., Lehar, M., Drachman, D.B. (1993) A novel Terapia for myasthenia gravis by reducing the endocytosis of ACETILCOLINA recettores. Ann New York Academy of Sciences 681:298-302.

20. Lopate, G., pestronk, A. (1993) Miastenia grave. Hospital Practice 28:109-131.

21. Kornberg, A.J., pestronk, A. (1993) Immune-mediata neuropatie. Current Opinion in Neurology 6:681-687.

22. Lopate, G., pestronk, A. (1994) The myasthenic neuromuscular junction. In Manobook of Miastenia grave, ed. R.P. Lisak, Marcel Dekker, Inc., New York, NY., pp. 225- 237.

23. Lopate G., pestronk A. Cronico immune demielinizzante neuropatie. Seminars in Neurol 1994;14(2):131-136.

24. Kornberg A.J., pestronk A. Cronico motor neuropatie: diagnosi, Terapia e pathogenesis. Ann Neurol 1995;37(S1):S43-S50.

25. Pestronk, A. Dimethylaminopropionitrile. Experimental e Clinica Neurotoxicology, Second Edition, Oxford University Press. 1997

26. Lee, KP, Yee, W-C, pestronk, A. Miastenia grave. Current Diagnosis 9, W.B. Saunders Co. 1996.

27. Pestronk, A. Cronico immune polineuropatia e serum autoanticorpi. Practical Neuroimmunology, eds LA Rolak, Y Harati, Butterworth Heinemann 1997;237-251.

28. Pestronk, A. Motorio neuropatie e più bassa motor neuron sindromi. Continuum 1997;3:99-110.

29. Pestronk, A. Familisono amyotrophic lateral sclerosis. Continuum 1997;3:71-74.

30. Pestronk, A. Malattie multisistemiche con preminente motor segni. Continuum 1997;3:75-77

31. Pestronk, A. Ereditarietà spastic paraplegia. Continuum 1997;3:78-82

32. Pestronk, A. Polyneuropatie e serum autoanticorpi to MAG, GALOP antigene, sulfatide e GM1 ganglioside. SRL Hokan Quarterly 1998;22:117-129.

33. Multifocal Neuropatia motoria: Diagnosis e Trattamento. Neurology 1998;51S;S22-S24.

34. Pestronk A. Dolore muscolare e cramps. In: Bradley WG, Daroff RB, Fenichel GM, Marsden CD, editors. Neurology in Clinica Practice 3a edition, Boston, MA: Butterworth-Heinemann. 2000, pp 397-402.

35. Pestronk A. Autoanticorpi e Immune Polyneuropatie. In: Katirji B, Kaminski HJ, preston DC, Ruff RL, Shapiro BE, editors. Neuromuscular Disorders in Clinica Practice. Boston, MA: Butterworth-Heinemann. 2002. pp 64-73.

36. Mozaffar T, pestronk A. Cancer-relativa Malattia muscolare. In: Karpati G, editor. Structural e Molecular Basis of Scheletro Muscoli diseases. Basel, Switzerland: ISN Neuropath Press. 2002. pp 266-269.

37. Pestronk A. Paraneoplastico Neuropatia Sindromi: Principali e Trattamento. In: Noseworthy JH, editor. Neurological Therapeutics, principles e Practice. London: Martin Dunitz. 2003. pp 2158-2165.

38. Kornberg AJ, pestronk A. anticorpi-associata polineuropatia sindromi: principles e trattamento. Semin Neurol. 2003;23:181-190.



PEER-REVIEWED PUBLICATIONS:

1. Toyka, K.V., Drachman, D.B., pestronk, A., e Kao, I. (1975) Miastenia grave: passive transfer from man to mouse. Science 190:397-99.

2. Pestronk, A., Drachman, D.B., e Griffin, J.W. (1976) Effects of Muscoli disuse on ACETILCOLINA recettores. Nature 260:352-353.

3. Toyka, K.V., Drachman, D.B., pestronk, A., Fischbeck, K.H., e Kao, I. (1976) A transferable "myasthenogenic" fattore in the serum dei pazienti con myasthenia gravis. J Neurol 212:271-280

4. Pestronk, A., Drachman, D.B., e Griffin, J.W. Effect of botulinum toxin on trophic regulation of ACETILCOLINA recettores. Nature 264:787-788.

5. Toyka, K.V., Drachman, D.B., Griffin, D.E., pestronk, A., Winkelstein, J.A., Fischbeck, K.H., e Kao, I. (1977) Miastenia grave: study of humoral immune mechanisms by passive transfer to mice. N Engl J Med 296:125-131.

6. Pestronk, A., e Drachman, D.B. (1978) A new stain for quantitative measurement of sprouting a neuromuscular junctions. Muscoli e Nervi 1:70-74.

7. Pestronk, A., Drachman, D.B. (1978) Motorio nerve sprouting e ACETILCOLINA recettores. Science 199:1223-1225.

8. Drachman, D.B., Adams, R.N., Stanley, E.F., e Pestronk, A. (1980) Meccanismi of ACETILCOLINA recettore perdita in myasthenia gravis. J Neurol Neurosurg Psychiatry 43:601-610.

9. Murphy, A., Drachman, D.B., Satya-Murti, S., pestronk, A., e Eggelston, J. (1980) Critical reexamination of the thymus immunization model of myasthenia gravis. Muscoli e Nervi 3:293-297.

10. Keogh, J.P., pestronk, A., Wertheimer, D., e Moreland, R.(1980) An epidemic of urinary retention caused by dimethylaminopropionitrile. JAMA 243:746-749.

11. Pestronk, A., Drachman, D.B., e Griffin, J.W. (1980) Effects of aging on nerve sprouting e rigenerazione. Exp Neurol 70:65-82.

12. Pestronk, A., Drachman, D.B., Stanley, E.F., price, D.L., e Griffin, J.W. (1980) Cholinergic transmission regulates extrajunctional ACETILCOLINA recettores. Exp Neurol 70:690-696.

13. Pestronk, A., e Drachman, D.B. (1980) Lithium reduces the numero of ACETILCOLINA recettores in skeletal Muscoli. Science 210:342-343.

14. Pestronk, A., e Drachman, D.B. (1980) Dimethyl sulfoxide reduces titers of antirecettore anticorpo in experimental myasthenia gravis. Nature 288:733-734.

15. Drachman, D.B., Stanley, E.F., pestronk, A., price, D.L., e Griffin, J.W. (1982) Neurotrophic regulation of two properties of skeletal Muscoli by impulse-dipendente e spontaneo ACh transmission. J Neurosci 2:232-243.

16. Pestronk, A., parhad, I.M., Drachman, D.B., e Price, D.L. (1982) Membrane miopatia: morphologic similarities to Duchenne's muscolare dystrophy. Muscoli e Nervi 5:209-214.

17. Pestronk, A., Drachman, D.B., Stanley, E.F., e Adams, R.N. (1982) Trattamento of ongoing experimental myasthenia gravis con short term alto dose cyclophosphamide. Muscoli e Nervi 5:79-84.

18. Pestronk, A., Drachman, D.B, Teoh, R., Adams, R.N. (1983) Combined short-term immunotherapy cures experimental autoimmune myasthenia gravis. Ann Neurol 14:235-241. 19. Pestronk, A., pestronk, S. (1983) Goggle migraine. N Engl J Med 301:226.

20. Andrew, C.G., Drachman, D.B., pestronk, A., Narayan, O. (1984) Susceptibility of skeletal Muscoli to Coxsackie A2 virus infezione: effects of botulinum toxin e denervation. Science 223:714-716.

21. Dellon, A.L., Mackinnon, S.E., pestronk, A. (1984) Implantation of dei nervi sensori dentro Muscoli: preliminary clinical e experimental observations on neuroma formation. Ann Plas Surg 12:30-34.

22. Pestronk, A., e Drachman, D.B. (1985) Polimiosite: reduction of ACETILCOLINA recettores in myasthenia gravis: clinical correlata. Muscoli e Nervi 8:233-239.

23. Pestronk, A., Drachman, D.B., e Self, S. (1985) Measurement of junctional ACETILCOLINA recettores in myasthenia gravis: clinical correlata. Muscoli e Nervi 8:245-251.

24. Pestronk, A., e Drachman, D.B. (1985) Motorio nerve terminale outgrowth: effects of a-bungarotoxin e anti-AChR anticorpo. J Neurosci 5:751-758.

25. Pestronk, A. (1985) Intracellular ACETILCOLINA recettores in skeletal Muscoli of the adulti rat. J Neurosci 5:1111-1117.

26. Drachman, D.B., Adams, R.N., McIntosh, K., pestronk, A. (1985) Trattamento of experimental myasthenia gravis con Cyclosporin A. Clin Immunol e Immunopath 34:174-188.

27. Pestronk, A., Teoh, R., Sims, C., Drachman, D.B. (1985) Effects of dimethylsulfoxide on humoral immune risposta to ACETILCOLINA recettores in rats. Clin Immunol Immunopath 37:172-178.

28. Malinow, K. Yannakakis, G.D., Glusman, S.M., Edlow, D.W., pestronk, A., powell, D.L., Ramsey-Goldman, R., Eidelman, G.H., Medsger, T.A., Jr., Alexander, E.L. (1986) subacuta sensorio neuropatia secondary to radice dorsale ganglionitis in primary Sjorgren's sindrome. Ann Neurol 20:535-537.

29. Kuncl, R.W., Rechthand, E., pestronk, A. (1986) Penicilliamine-induced myasthenia gravis associata con ridotta ACETILCOLINA recettores. Ann Neurol 20:740-743.

30. Pestronk, A., e Drachman, D.B. (1987) Meccanismo of action on lithium on ACETILCOLINA recettore metabolism in skeletal Muscoli. Brain Res 412:302-310.

31. Yee, W.C., e Pestronk, A. (1987) Meccanismi of postsynaptic plasticity: remodeling of the junctional ACETILCOLINA recettore cluster induced by motor nerve terminale outgrowth. J Neurosci 7:2019-2024.

32. Pestronk, A. (1988) The first neurology book: De Cerebri Morbis... (1549) by Jason Pratensis. Arch Neurol 45:341-344.

33. Pestronk, A., e Drachman, D.B. (1988) Motorio nerve outgrowth: ridotta capacità for sprouting in the terminals of longer assoni. Brain Res 463:216-222.

34. Yee, W.C., Drachman, D.B., Walser, M., e Pestronk, A. (1988) Effect of ketoleucine trattamento on atrofia of skeletal Muscoli. Exp Neurol 99:1-9.

35. Pestronk, A., Cornblath, D.R., Ilyas, A.A., Baba, H., Quarles, R.H., Griffin, J.W., e Alderson, K. (1988) A treatable multifocal motor neuropatia con anticorpi to GM1 ganglioside. Ann Neurol 24:73-78.

36. Pestronk, A., Adams, R.N., Clawson, L., Cornblath, D.R., Kuncl, R.W., Griffin, D., e Drachman, D.B. (1988) serico anticorpi to GM1 ganglioside in amyotrophic lateral sclerosis. Neurology 38:1457-1461.

37. Pestronk, A. (1988) The first neurology book written in English: "De Morbis Capitis" (1650). Arch Neurol 46:215-220.

38. Ramsay, D.A., Drachman, D.B., e Pestronk, A. (1988) Rapido sintesi of ACETILCOLINA recettores a neuromuscular junctions. Brain Res 46:215-220.

39. Yee, W.C., pestronk, A., Alderson, K., Yuan, C.M. (1988) Regional eterogeneicità in the distal motor axon: three zones con distinctive intrinsic components. J Neurocytol 17:649-656.

40. Pestronk, A., Adams, R.N. Kuncl, R.W., Drachman, D.B., Clawson, L.L., e Cornblath, D. (1988) differenziale effects of prednisone e cyclophosphamide on autoanticorpi in umana neuromuscular Malattie. Neurology 39:628-633.

41. Alderson, K., pestronk, A., Yee, W.C., e Drachman, D.B. (1989) Silver cholinesterase immunocytochemistry: a new neuromuscular junction stain. Muscoli e Nervi 12:9-14.

42. Kuncl, R.W., pestronk, A., Alexander, E., Valee, D., Lane, J. (1989) The MRL +/+ mouse: a new model of tubular aggregati which sono gender e age-relativa. Acta Neuropath 78:615-620.

43. Crain, E., McIntosh, K.R., Gordon, G., pestronk, A., Drachman, D.B. (1989) The effect of thalidomide on experimental autoimmune myasthenia gravis. J Autoimmun 2:197-202.

44. McArthur, J.C., Marek, K., pestronk, A., McArthur, J., peroutka, S.J. (1989) Nifedipine in the prophylaxis of classic migraine: A crossover, double-masked, placebo-controllata study of headache frequenza e effetti collaterali. Neurology 39:284-286.

45. Pestronk, A., Adams, R.N., Cornblath, D., Kuncl, R.W., Drachman, D.B., e Clawson, L. (1989) Patterns of serum IgM anticorpi to GM1 e GD1a gangliosides in ALS. Ann Neurol 25:98-102 46. Alderson, K., Yee, W.C., pestronk, A. (1989) Reorganization of intrinsic components in the distal motor axon durante outgrowth. J Neurocytol 18:541-552.

47. Baba, H., Daune, G.C., pestronk, A., Cornblath, D.R., Chaudhry, V., Griffin, J.W., Quarles, R.H. (1989) Anti-GM1 ganglioside anticorpi con differing fine specificities in pazienti con multifocal motor neuropatia. J Neuroimmunol 25:143-150.

48. Lipsky, N.G., Drachman, D.B., pestronk, A., Shih, p. (1989) Neural regulation of mRNA for the a-Subunità of ACETILCOLINA recettores: Ruolo of neuromuscular transmission. Exp Neurol 105:177-183.

49. Marcus, D.M., Latov, N., Hsi, B.P., Gillard, B.K., e Participating Laboratories. (1989) Report of a conference: Measurement e significance of anticorpi vs GM1 ganglioside. J Neuroimmunol 25:251-259.

50. Avila, O.L., Drachman, D.B., pestronk, A. (1989) Neurotransmission regulates stabilità of ACETILCOLINA recettores a the neuromuscular junction. J Neurosci 9:2902-2906.

51. Pestronk, A., Watson, D.F., Yuan, C.M. (1990) Neurofilament phosphorylation nei nervi periferici: cambiamenti con axonal length e crescita state. J Neurochem 54:977-982.

52. Krarup, C., Stewart, J.D., Sumner, A.J., pestronk, A., Lipton, S.A. (1990) A sindrome of asimmetriche limb debolezza con motor conduction block. Neurology 40:118-127.

53. Pestronk, A., Chaudhry, V., Feldman, E.L., Griffin, J.W., Cornblath, D.R., Denys, E.N., Glasberg, M., Kuncl, R.W., Olney, R.K., Yee, W.C. (1990) inferiori motor neuron sindromi defined by patterns of debolezza, nerve conduction anormalità e alto titers of antiglycolipid anticorpi. Ann Neurol 27:316-326.

54. Rothstein, J.D., Guochuan, T., Kuncl, R.W., Clawson, L., Cornblath, D.R., Drachman, D.B., pestronk, A., Stauch, B.L., e Coyle, J.T. (1990) Anormalee excitatory aminoacido metabolism in amyotrophic lateral sclerosis. Ann Neurol 28:18-25.

55. Li, F., pestronk, A. (1991) Autoanticorpi to GM1 ganglioside: Different reactivity to GM1-liposomes in amyotrophic lateral sclerosis e più bassa motor neuron Malattie. J Neurol Sci 104:209-214.

56. Pestronk, A., Li, F., Griffin, J., Feldman, E.L., Cornblath, D., Trotter, J., Zhu, S., Yee, W.C., phillips, D., Winslow, B. (1991) Polineuropatia sindromi associata con serum anticorpi to sulfatide e myelin-associata glicoproteina. Neurol 41:357-362.

57. Griggs, R.C., Moxley, R.T., Mendell, J.R., Fenichel, G.M., Brooke, M.H., pestronk, A., Miller, J.P., et al. (1991) Prednisone in Duchenne dystrophy: A randomized, controllata trial defining the tempo course e dose risposta. Arch Neurol 48:383-388.

58. Selnes, O.A., pestronk, A., Hart, J., e Gordon, B. (1991) Limb atassia senza aphasia from a left-sided lesion in a right-hander. J Neurol Neurosurg Psychiat 54(8):734-737.

59. Fenichel, G.M., Mendell, H.R., Moxley, R.T., Griggs, R.C., Brooke, M.H., Miller, J.P., pestronk, A., Robison, J., King, W., Signore, L., pandya, M.S., Florence, J., Schierbecker, J., Wilson, B. (1991) A comparison of daily e alternate-giorno prednisone Terapia in the trattamento of Duchenne muscolare dystrophy. Arch Neurology 48:575-579.

60. Feldman, E.L., Bromberg, M.B., Albers, J.W., pestronk, A. (1991) Immunosuppressive trattamento in multifocal motor neuropatia. Ann Neurol 30:397-401.

61. Cornblath, D.R., Kuncl, R.W. Mellits, E.d., Quaskey, S.A., Clawson, L., pestronk, A. Drachman, D.B. (1992) Conduzione nervosa studies in Amyotrophic Lateral Sclerosis. Muscoli e Nervi 15:1111-1115.

62. Chaudhry, V., pestronk, A. (1992) Different patterns of glycolipid anticorpo reactivity: inferiori motor neuron sindromi contro immunization. J Neuroimmunol 36:127-134.

63. Griggs, R.C., Moxley III, R.T., Mendell, J.R., Fenichel, G.M., Brooke, M.H., pestronk, A., Miller, J.P., Cwik, V.A., pandya, S., Robison, J., King, W., Signore, L., Schierbecker, J., Florence, J., Matheson-Burden, N., Wilson, B. (1993) Duchenne dystrophy: Randomized, controllata trial of prednisone (18 mesi) e azathioprine (12 mesi). Neurology 43:520-527.

64. Connolly, A.M., pestronk, A., Trotter, J.L., Feldman, E.L., Cornblath, D.R., Olney, R.K. (1993) alta-titer selettiva serum anti-b-tubulin anticorpi in cronica infiammatorie demielinizzante polineuropatia. Neurology 43:557-562.

65. Kornberg, A.J., pestronk, A. (1994) The clinical e diagnostic role of anti-GM1 anticorpo testing. Muscoli e Nervi 17:100-104.

66. Kornberg, A.J., pestronk, A., Bieser, K., Ho, T.W., McKhann, G.M., Wu, H.S., Jiang, Z. The clinical correlata of alto titer IgG anti-GM1 anticorpi. Ann Neurol 1994;35:234-237.

67. Al-Lozi, M., pestronk, A., Yee, W.C., Flaris, N., Cooper, J. (1994) Rapidly Evolving Miopatia con Miosina-Deficient fibre muscolaris. Ann Neurol 94:35;273- 279. 68. Wax, MB, Barrett DA, pestronk A. Aumentato Incidenza of Paraproteinemia e Autoanticorpi in Pazienti con Normale Pressure Glaucoma. Am J Ophthalmology 1994;5(117):561-568.

69. Elliott, J, pestronk, A. Progressione of Multifocal Neuropatia motoria During Apparently Successful Trattamento con Umano Immune Globulin. Neurology 1994;44:967-968.

70. Pestronk, A., Li, F., Bieser, K., Choksi, R., Whitton, A., Kornberg, A.J. (1994) Anti-MAG anticorpi: Maggiore effects of antigene purity e anticorpo cross-reactivity on ELISA results e clinical correlazione. Neurology 1994;44:1131-1137.

71. Drachman, D.B., Chaudhry V., Cornblath, D., Kuncl R.W., pestronk, A., et al. Trial of immunosopressione in ALS, using total lymphoid irradiation. Ann Neurol 1994;35:142-150.

72. Zielasek J., Ritter G., Magi S, Hartung H.P., Toyka K.V., e participating laboratories. A comparative trial of anti-glycoconjugate anticorpo assays: IgM anticorpi to GM1. J. Neurol. 1994;241:475-480.

73. Al-Lozi M.T., pestronk A., Yee W.C., Flaris N. Miopatia e paraproteinemia con serum IgM legante to a alto molecular weight fibre muscolari surface proteina. Ann Neurol 1995;37:41-46.

74. Pestronk, A., Choksi, R., Bieser, K., Goldstein, J.M., Adler, C.H., Caselli, R.J., George, E.B. Treatable Andadura Disorder e Polineuropatia Associata con alta Titer serico IgM Binding to Antigens that Co-Purify con Myelin Associata Glycoprotein Muscoli e Nervi 1994 17:1293-1300.

75. Pestronk A., Lopate G., Kornberg A.J., Elliott J.L., Blume G., Yee W-C, Goodnough L.T. Distale più bassa motor neuron sindrome con alto titer serum IgM anti-GM1 anticorpi: miglioramento following immunotherapy con monthly plasma excambiamenti e intravenous cyclophosphamide. Neurology 1994 44:2027-2031.

76. Romano C., Barrett D.A., Li Z., pestronk A., Wax M.B. Anti-Rhodopsin anticorpi in pazienti con normalee pressure glaucoma. Investigative Opthal. 1995;10:1968-1975.

77. Cedarbaum, J.M., Charatan, M., Stambler, N., Lagunowich, L., Zhan, C., Radka, S., Morrisey, D., Lakings,D., Brooks, B.R., Sanjak, M., pestronk, A., Florence, J., Mitsumoto, H., Szirony, K., Bittle, L., Ringel, S., Neville, H., Brinkmann, J. The Pharmacokinetics of Subcutaneously Administered Recombinant Umano Ciliary Neurotrophic Factor (rHCNTF) in Pazienti con Amyotrophic Lateral Sclerosis: Relationship to Parameters of the Acuto Phase Risposta. Clin Neuropharm 1996;18:500-532.

78. Cedarbaum JM, Brooks BR, pestronk A, Mitsumoto H, Neville H, Wittes J. A phase I study of recombinant umana ciliary neurotrophic fattore (rHCNTF) in pazienti con amyotrophic lateral sclerosis. Clin Neuropharm 1995;18:515-532.

79. Blume G., pestronk A., Goodnough L.T. Anti-MAG anticorpo associata polineuropatia: miglioramento following immunotherapy con monthly plasma excambiamenti e intravenous cyclophosphamide. Neurology 1995;45:1577-1580.

80. ALS CNTF Trattamento Study (ACTS) Phase I-II Study Group. The amyotrophic lateral sclerosis functional rating scale. Arch. Neurol. 1996;53:141-147.

81. ALS CNTF Trattamento Study (ACTS) Study Group: A double-blind placebo-controllata clinical trial of subcutaneous recombinant umana ciliary neurotrophic fattore (rHCNTF) in Amyotrophic Lateral Sclerosis. Neurology, 1996;46:1244-1249.

82. Connolly, AM, pestronk, A, et al. Congenite muscolare dystrophy sindromi distinguished by alkaline e acido phosphatase, merosin, e dystrophin colorazione. Neurology 1996;46:810-814.

83. Nevo, Y, pestronk, A, et al. Infanzia cronica infiammatorie demielinizzante neuropatie: Clinica course e lunga-term follow-up. Neurology 1996;47:98-102.

84. Santorelli, FM, Sciacco, M. et al. Multiple mitocondriale DNA delezioni in sporadica inclusion body miosite: A study of 56 pazienti. Ann. Neurol 1996;39:789-795.

85. Nevo, Y, pestronk A. Neonatale perifascicolare miopatia. Pediatric Neurology 1996 15(2):150-152.

86. Nevo, Y, pestronk A, et al. Neuropatia of metachromatic leukodystrophy: miglioramento con immunomodulation. Pediatric Neurology 1996;15:237-239.

87. Kornberg, AJ, pestronk A, et al. Selettiva colorazione of the cerebellar molecular layer by serum IgG in Miller-Fisher e relativa sindromi. Neurology 1996;47:1317-1320.

88. Connolly, AM, pestronk, A, et al. serico IgM monoclonal autoantibody legante to the 301-314 aminoacido epitope of b-tubulin: Clinica correlazione con lentamente progressive demielinizzante polineuropatia. Neurology 1997;48:243-248.

89. Blume, G, pestronk, A, et al. Polimiosite con citocromo ossidasi negative Fibre muscolari: Precoce quadriceps debolezza e poor risposta to immunosopressivo Terapia. Brain 1997;120:39-45.

90. Duggan, DJ, Gorospe, R, Fanin, MS, Hoffman, EP, Angelini, C, pegoraro, E, Noguchi, S, Ozawa, E, pendlebury, W, Waclawik, AJ, Duenas, DA, Hausmanowa- Petrusewicz, I, Fidzianska, A, Bean, SC, Haller, JS, Bodensteiner, J, Greco, CM, pestronk, A, Berardinelli, A, Gelinas, DF, Abram, H, Kuncl, R. Mutazioni in the sarcoglycan genes in pazienti con miopatia. N Engl J Med 1997;336:618-624.

91. Pestronk, A, Choksi R, Blume, G, Lopate, G. Multifocal motor neuropatia: serico IgM legante to a GM1-ganglioside containing lipid mixture ma not to GM1 da solo. Neurology 1997;48:1104-1106.

92. Fenichel, G, pestronk, A, Florence, J, Robison, V, Hemelt, VB. A beneficial effect of oxandrolone in the trattamento of Duchenne muscolare dystrophy: A pilot study. Neurology 1997;48:1225-1226.

93. Lopate, G, parks BJ, Goldstein, JM, Yee,, WC, Friesenhahn GM, pestronk, A. Polyneuropatie associata con alto-titer anti-sulfatide anticorpi: Characteristics dei pazienti con e senza serum Proteina M. J Neurol Neurosurg Psychiatry 1997;62:581-585.

94. Connolly, AM, pestronk, A, Mehta, S, pranzatelli, MR, Noetzel, MJ. serico autoanticorpi in infantili opsoclonus-myoclonus sindrome: An analysis of antigenic targets in neural tessuti. J Pediatr 1997;130:878-884.

95. Lopate, G, pestronk, A, Kornberg, AJ. IgM anti-sulfatide autoanticorpi: Patterns of legante to cervelletto, radice dorsale gangli e periferica nerve. J Neurol Sci 1997;151:189-197.

96. Nevo, Y, pestronk, A. Acuto immune neuropatie: serico anticorpi to Campylobacter jejuni, Helicobacter pylori, e GM1 ganglioside. J Infect Dis 1997;176(Suppl2):S154-156

97. Pestronk, A., Choksi, R. Multifocal motor neuropatia: serico IgM anti-GM1 ganglioside anticorpi in maggior parte pazienti detected using covalent collegamento of GM1 to ELISA plates. Neurology 1997;49:1289-1292

98. Al-Lozi, MT, pestronk, A, Choksi, R. A skeletal Muscoli-specific forma of decorin è a target antigene for a serum IgM Proteina M in a paziente con a prossimale miopatia. Neurology 1997;49:1650-1654

99. Connolly, AM, pestronk, A. Anti-tubulin autoanticorpi in acquisita demielinizzante polineuropatia. J Infect Dis 1997;176(Suppl2):S157-159

100. Levin, MI, Mozaffar, T, Al-Lozi, MT, pestronk, A. Paraneoplastico necrotizing miopatia: Clinica e pathological caratteristiche. Neurology 1998;50:764-767.

101. Stambler, NL, Charatan, M, Cedarbaum, JM e the ALS CNTF Study Group. Prognostic indicators of survival in ALS. Neurology 1998;50:66-72.

102. Al-Lozi, MT, Hemelt VB, pestronk, A. Steroidi-rispondenti miopatia con carenza di solfato di condroitina C in skeletal Muscoli connettivo tessuto. Neurology 1998;50:526-529.

103. Lopate, G, pestronk, A, Yee, WC. N lines in a miopatia con myosin perdita. Muscoli Nervi 1998;21:1216-1219.

104. Mozaffar, T, pestronk, A. Clinica correlata of granulomi in Muscoli. J. Neurol 1998; 245:519-524.

105. Connolly, AM, pestronk, A, Mehta, S, Al-Lozi, M. autosomica recessiva muscolare dystrophy con primary a-sarcoglycan (adhalin) Carenza rispondenti to prednisone. Muscoli Nervi 1998;21:1549-1553.

106. Levine, T, pestronk, A. Miopatie infiammatorie con citocromo ossidasi negative Fibre muscolari: Metotressaal trattamento. Muscoli Nervi 1998;12:1724-1728.

107. Pestronk, A, Choksi, R, Yee, WC, Kornberg, AJ, Lopate, G, Trotter J. serico anticorpi to heparan sulfate glycosaminoglycans in Guillain-Barré sindrome e altre demielinizzante polineuropatia. J. Neuroimmunol 1998;91:204-209.

108. Connolly AM, Chez MG, pestronk, A, Arnold ST, Mehta, S, Deuel RK. serico autoanticorpi to encefalo in Landau-Kleffner variante, autism, e altre neurologic Malattie. J Pediat 1999;134:607-613.

109. Levine, TD, pestronk, A. IgM anticorpo-relativa polineuropatia: Trattamento con Cellule B depletion chemotherapy using rituximab. Neurology 1999;52:1701-1704.

110. Nevo, Y, Al-Lozi, M, parsadanian, AS, Elliott, JL, Connolly, AM, pestronk. A. Mutazione analysis in Emery-Dreifuss muscolare dystrophy. Pediatric Neurology 1999;21:456-459.

111. Patton BL, Connolly, AM., Martin PT, Cunningham JM, Mehta S, pestronk A, Miner JH, Sanes JR. Distribuzione of ten laminin chains in dystrophic e regenerating Muscoli. Neuromuscular Disorders 1999;9:423-433.

112. Calhoun RF, Ritter JH, Guthrie TJ, pestronk A, Meyers BF, patterson GA, pohl MS, Cooper JD. Risultati of transcervical thymectomy for myasthenia gravis in 100 consecutive pazienti. Annals of Surgery 1999;230:555-561.

113. The BDNF Study Group (Phase III). A controllata trial of recombinant methionyl umana BDNF in ALS. Neurology. 1999;52:1427-1433.

114. Mozaffar T, pestronk A. Miopatia con anti-Jo-1 anticorpi: patologia in perimisio e neighbouring Muscoli fibres. J Neurol Neurosurg Psychiatry 2000;68:472-478.

115. Chiesa R, pestronk A, Schmidt RE, Tourtellotte WG, Ghetti B, piccardo P, Harris DA. Primari miopatia e accumulation of prp(sc)-like molecole in periferica tessuti of transgenic mice expressing a prion proteina insertional mutazione. Neurobiol Dis. 2001;8:279-288.

116. Fenichel GM, MD, Griggs RC, Kissel J, Kramer, TI, Mendell JR, Moxley RT, pestronk A, Sheng K, Florence J, King WM, pandya MS, Robison VD, Wang H. A randomized efficacy e safety trial of oxandrolone in the trattamento of Duchenne dystrophy. Neurology 2001;56:1075-1079.

117. Lopate G, Kornberg AJ, Yue J, Choksi R, pestronk A. Anti-myelin associata glicoproteina anticorpi: variability in patterns of IgM legante to periferica nerve. J Neurol Sci 2001;188:67-72.

118. Connolly AM, Keeling RM, Mehta S, pestronk A, Sanes JR. Three mouse models of muscolare dystrophy: the natural history of strength e fatigue in dystrophin-, dystrophin/utrophin-, e laminin alpha2-carenza mice. Neuromuscul Disord 2001;11:703-712.

119. Kovach MJ, Waggoner B, Leal SM, Gelber D, Khardori R, Levenstien MA, Shanks CA, Gregg G, Al-Lozi MT, Miller T, Rakowicz W, Lopate G, Florence J, Glosser G, Simmons Z, Morris JC, Whyte MP, pestronk A, Kimonis VE. Clinica Delineation e Localization to Cromosoma 9p13.3-p12 of a Unique Dominante Disorder in Four Families: Ereditarietà Inclusion Body Miopatia, paget Malattia of Ossa, e Frontotemporal Demenza. Molecular Genetica e Metabolism 2001;74:458-475.

120. Lopate G, Choksi R, pestronk A. Gravi sensorio atassia e demielinizzante polineuropatia con IgM anti-GM2 e GalNAc-GD1A anticorpi Muscoli Nervi 2002;25;828-836.

121. Connolly AM, Keeling RM, Streif EM, pestronk A, Mehta S. Complement 3 Carenza e orale prednisolone improve strength e prolong survival of laminin alpha2-carenza mice. J Neuroimmunol 2002;127:80-87.

122. Miller T, Al-Lozi MT, Lopate G, pestronk A. Miopatia con anticorpi to the segnale riconoscimento Particelle: clinical e pathological caratteristiche. J Neurol Neurosurg Psychiat 2002;73:420-428.

123. Pestronk A, Choksi R, Logigian E, Al-Lozi MT. Neuropatia sensoria con Monoclonal IgM Binding to a Trisulfated Heparin Disaccharide. Muscoli Nervi 2003;27:188-95.

124. Pestronk A, Florence J, Miller T, Choksi R, Al-Lozi MT, Levine TD. Trattamento of IgM anticorpo-associata polineuropatia using Ritussimab. J Neurol Neurosurg Psychiat 2003;74:485-489.

125. Stone MJ, McElroy YG, pestronk A, Reynolds JL, Newman JT, Tong AW. Umano monoclonal macroglobulins con anticorpo attività. Semin Oncol 2003;30:318-324.

126. Gertz MA, Anagnostopoulos A, Anderson K, Branagan AR, Coleman M, Frankel SR, Giralt S, Levine T, Munshi N, pestronk A, Rajkumar V, Treon SP. Trattamento recommendations in Waldenström's macroglobulinemia: Consensus Panel Recommendations from the Second International Workshop on Waldenström's Macroglobulinemia. Semin Oncol 2003;30:121-126.

127. Watts GDJ, Thorne M,Kovach MJ, pestronk A, Kimonis VE. Clinica e genetic eterogeneicità in chromosome 9p associata hereditary inclusion body miopatia: exclusion of GNE e three altre candidate genes. Neuromuscular Disorders 2003;13:559-567.

128. Pestronk A, Florence J, Levine T,Al-Lozi MT, Lopate G, Miller T, Ramneantu I, Waheed W,Stambuk M. Sensorio exam con a quantitative tuning fork Rapido, sensitive e predictive of SNAP ampiezza. Neurology 2004;62:461-464.

129. Watts GDJ, Wymer J, Kovach MJ, Mehta SG, Mumm S, Darvish D, pestronk A, Whyte MP, Kimonis VE. Inclusion body miopatia associata con Paget malattia of bone e frontotemporal dementia è caused by mutant valosin-containing proteina. Nature Genetica 2004;36:377-381.

130. Meininger V, Bensimon G, Bradley WG, Brooks BR, Douillet P, Eisen AA, Lacomblez L, Leigh PN, Robberecht W e altre investigators. Efficacy e safety of xaliproden in amyotrophic lateral sclerosis: results of two phase III trials. Amyotroph Lateral Scler Altro Motorio Neuron Disord 2004;5:107-117.

131. Simpson D, Estanislao L, Evans S, McArthur J, Marcus K, Truffa M, Lucey B, Naismith R, Lonergan JT, Clifford D e the HIV Neuromuscular Sindrome Study Group. HIV associata neuromuscular debolezza sindrome. AIDS 2004;18:1403-1412.

132. Shefner JM, Cudkowicz ME, Schoenfeld D, Conrad T, Taft J, Chilton M, Urbinelli L, Qureshi M, Zhang H, pestronk A, Caress J, Donofrio P, Sorenson E, Bradley W, Lomen- Hoerth C, pioro E, Rezania K, Ross M, pascuzzi R, Heiman-Patterson T, Tandan R, Mitsumoto H, Rothstein J, Smith-Palmer T, Macdonald D, Burke D. A clinical trial of creatine in ALS. Neurology 2004;63:1656-1661.

133. Lopate G, pestronk A, Al-Lozi M. Trattamento of Cronico Infiammatorie Polineuropatia demielinizzante Con alta-Dose Intermittente Intravenous Methylprednisolone. Arch Neurol 2005;62:249-254.
Ritorno a Alan Pestronk
2/16/2005

Ritorno a Fonama.org Home Page

Alla pagina originale

Hit Counter